NCT02873962 2026-04-01A Phase II Study Of Nivolumab/ Bevacizumab/RucaparibDana-Farber Cancer InstitutePhase 2 Active not recruiting72 enrolled 16 charts
NCT04624178 2025-11-20A Study of Rucaparib and Nivolumab in People With LeiomyosarcomaMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting20 enrolled
NCT02678182 2025-06-10PLATFORMRoyal Marsden NHS Foundation TrustPhase 2 Active not recruiting494 enrolled